Loading...

The current price of SRDX is 42.99 USD — it has increased 0.35 % in the last trading day.
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
Wall Street analysts forecast SRDX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SRDX is USD with a low forecast of 32.00 USD and a high forecast of 32.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Surmodics Inc revenue for the last quarter amounts to 29.57M USD, decreased -2.55 % YoY.
Surmodics Inc. EPS for the last quarter amounts to -0.37 USD, decreased -30.19 % YoY.
Surmodics Inc (SRDX) has 389 emplpoyees as of December 15 2025.
Today SRDX has the market capitalization of 598.49M USD.